Head & Neck/Thyroid Cancers
Conference Coverage
ASCO goes ahead online, as conference center is used as hospital
News from the FDA/CDC
FDA approves selpercatinib for lung and thyroid RET tumors
From the Journals
COVID-19 death rate was twice as high in cancer patients in NYC study
The overall case fatality rate was 28% for cancer patients with COVID-19 and 14% for noncancer COVID-19 patients.
From the Journals
Excess cancer deaths predicted as care is disrupted by COVID-19
Conference Coverage
Antitumor treatment may increase risk of severe events in COVID-19 patients
Conference Coverage
Metastatic cancer linked to worse outcomes of COVID-19
From the Journals
COVID-19: Defer ‘bread and butter’ procedure for thyroid nodules
Of asymptomatic thyroid nodules, 90% are benign.
Feature
ASCO panel outlines cancer care challenges during COVID-19 pandemic
Feature
Will coronavirus restrictions lead to more advanced cancers?
From the Journals
European cancer centers restructure care in the era of COVID-19
From the Journals
Want to keep cancer patients and providers safe during the pandemic? Here’s how
Prescreening, telemedicine, and limited interventions top the list of best practices for patients, while PPE, telecommuting, and wellness/stress...